(Q37677908)
Statements
1 reference
Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma (English)
1 reference
1 reference
Axel Hauschild
1 reference
John M Kirkwood
1 reference
Peter Hersey
1 reference
David McDermott
1 reference
Margaret A Marshall
1 reference
Jesus Gomez-Navarro
1 reference
Jane Q Liang
1 reference
Cecile A Bulanhagui
1 reference
19 January 2010
1 reference
1 reference
Identifiers
1 reference